Lennar Corporation (LEN) Stock Forecast
Data as of Jun 16, 2026Consumer Cyclical · Current price $89.74 (-0.04%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 6, 2026 | John Lovallo | UBS | $122.00 | +35.9% |
| Dec 18, 2025 | John Lovallo | UBS | $137.00 | +52.7% |
| Dec 18, 2025 | Susan Maklari | Goldman Sachs | $120.00 | +33.7% |
| Dec 18, 2025 | Matthew Bouley | Barclays | $88.00 | -1.9% |
| Dec 8, 2025 | Matthew Bouley | Barclays | $98.00 | +9.2% |
| Sep 22, 2025 | Aaron Hecht | JMP Securities | $140.00 | +56.0% |
| Oct 7, 2024 | Sam Reid | Wells Fargo | $190.00 | +111.7% |
| Sep 24, 2024 | Stephen Kim | Evercore ISI | $236.00 | +163.0% |
| Sep 23, 2024 | Rafe Jadrosich | Bank of America Securities | $190.00 | +111.7% |
| Sep 23, 2024 | Anthony Pettinari | Citigroup | $196.00 | +118.4% |
| Sep 23, 2024 | Carl Reichardt | BTIG | $216.00 | +140.7% |
| Sep 23, 2024 | Mike Dahl | RBC Capital | $160.00 | +78.3% |
| Sep 23, 2024 | Susan Maklari | Goldman Sachs | $190.00 | +111.7% |
| Sep 20, 2024 | Susan Maklari | Goldman Sachs | $182.00 | +102.8% |
| Sep 9, 2024 | Sam Reid | Wells Fargo | $205.00 | +128.4% |
| Jul 22, 2024 | Susan Maklari | Goldman Sachs | $174.00 | +93.9% |
| Jun 20, 2024 | Mike Dahl | RBC Capital | $145.00 | +61.6% |
| Jun 20, 2024 | Susan Maklari | Goldman Sachs | $180.00 | +100.6% |
| Jun 20, 2024 | Stephen Kim | Evercore ISI | $237.00 | +164.1% |
| Jun 20, 2024 | Matthew Bouley | Barclays | $177.00 | +97.2% |
Top Analysts Covering LEN
LEN vs Sector & Market
| Metric | LEN | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.44 | 2.51 | 2.40 |
| Analyst Count | 27 | 12 | 19 |
| Target Upside | +9.6% | +387.4% | +17.1% |
| P/E Ratio | 12.88 | 13.80 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-11-30 | $31.57B | $32.98B | $33.68B | 7 |
| 2027-02-28 | $6.78B | $6.98B | $7.13B | 3 |
| 2027-05-28 | $7.86B | $8.10B | $8.27B | 3 |
| 2027-08-28 | $8.87B | $9.13B | $9.33B | 3 |
| 2027-11-28 | $9.53B | $9.81B | $10.02B | 3 |
| 2027-11-30 | $32.64B | $34.10B | $34.95B | 7 |
| 2028-02-28 | $7.61B | $7.84B | $8.01B | 2 |
| 2028-05-28 | $8.61B | $8.86B | $9.05B | 2 |
| 2028-08-28 | $9.38B | $9.66B | $9.86B | 2 |
| 2028-11-28 | $10.29B | $10.59B | $10.82B | 2 |
| 2028-11-30 | $36.73B | $37.03B | $37.32B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-11-30 | $5.64 | $6.16 | $7.05 | 11 |
| 2027-02-28 | $1.03 | $1.07 | $1.10 | 3 |
| 2027-05-28 | $1.59 | $1.65 | $1.70 | 3 |
| 2027-08-28 | $2.14 | $2.22 | $2.29 | 3 |
| 2027-11-28 | $2.60 | $2.70 | $2.77 | 3 |
| 2027-11-30 | $6.06 | $7.54 | $8.44 | 12 |
| 2028-02-28 | $1.89 | $1.96 | $2.01 | 4 |
| 2028-05-28 | $2.61 | $2.71 | $2.79 | 4 |
| 2028-08-28 | $3.29 | $3.42 | $3.52 | 4 |
| 2028-11-28 | $4.15 | $4.31 | $4.43 | 4 |
| 2028-11-30 | $5.86 | $9.55 | $15.10 | 4 |
Frequently Asked Questions
What is the analyst consensus for LEN?
The consensus among 27 analysts covering Lennar Corporation (LEN) is Hold with an average price target of $102.14.
What is the highest price target for LEN?
The highest price target for LEN is $238.00, set by Stephen Kim at Evercore ISI on 2024-03-15.
What is the lowest price target for LEN?
The lowest price target for LEN is $60.00, set by Kenneth Zener at KeyBanc on 2022-06-29.
How many analysts cover LEN?
27 analysts have issued ratings for Lennar Corporation in the past 12 months.
Is LEN a buy or sell right now?
Based on 27 analyst ratings, LEN has a consensus rating of Hold (3.44/5) with a +9.6% upside to the consensus target of $102.14.
What are the earnings estimates for LEN?
Analysts estimate LEN will report EPS of $6.16 for the period ending 2026-11-30, with revenue estimated at $32.98B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.